Ruhi Kamran

417 total citations
11 papers, 162 citations indexed

About

Ruhi Kamran is a scholar working on Molecular Biology, Oncology and Hepatology. According to data from OpenAlex, Ruhi Kamran has authored 11 papers receiving a total of 162 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Hepatology. Recurrent topics in Ruhi Kamran's work include TGF-β signaling in diseases (2 papers), Quinazolinone synthesis and applications (2 papers) and Hepatitis C virus research (2 papers). Ruhi Kamran is often cited by papers focused on TGF-β signaling in diseases (2 papers), Quinazolinone synthesis and applications (2 papers) and Hepatitis C virus research (2 papers). Ruhi Kamran collaborates with scholars based in United States, Japan and Italy. Ruhi Kamran's co-authors include Mark S. Hixon, Charles E. Grimshaw, Andy Jennings, Douglas R. Dougan, Akiyoshi Tani, M. Sabat, Koji Takeuchi, Takuo Kosaka, Nobuhiro Nishigaki and Hiroki Sano and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and Molecular Cancer Therapeutics.

In The Last Decade

Ruhi Kamran

10 papers receiving 158 citations

Peers

Countries citing papers authored by Ruhi Kamran

Since Specialization

Citations

This map shows the geographic impact of Ruhi Kamran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruhi Kamran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruhi Kamran more than expected).

Fields of papers citing papers by Ruhi Kamran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruhi Kamran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruhi Kamran. The network helps show where Ruhi Kamran may publish in the future.

Co-authorship network of co-authors of Ruhi Kamran

This figure shows the co-authorship network connecting the top 25 collaborators of Ruhi Kamran. A scholar is included among the top collaborators of Ruhi Kamran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruhi Kamran. Ruhi Kamran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	De novo discovery of cyclic peptide inhibitors of IL-11 signaling 2024 ·Bioorganic & Medicinal Chemistry ·(unknown), Rosalba Tafi, (unknown), (unknown), Ruhi Kamran, (unknown), Tony Gibson, Jing Li, Bertram Bleck, Claudia Dall’Armi, Anna Demartis, Antoine Henninot	1
2	MET Tyrosine Kinase Inhibition Enhances the Antitumor Efficacy of an HGF Antibody 2017 ·Molecular Cancer Therapeutics ·(unknown), (unknown), Deepika Balakrishna, Shweta Pandya, Mark S. Hixon, Ruhi Kamran, (unknown), J. David Lawson, Kengo Okada, Akira Hori, Akio Mizutani, Hidehisa Iwata, Ron de Jong, Barbara Hibner, Patrick W. Vincent	11
3	Design, synthesis and optimization of 7-substituted-pyrazolo[4,3-b]pyridine ALK5 (activin receptor-like kinase 5) inhibitors 2017 ·Bioorganic & Medicinal Chemistry Letters ·M. Sabat, Haixia Wang, (unknown), J. David Lawson, (unknown), Ruhi Kamran, Mark S. Hixon, Douglas R. Dougan	18
4	Trelagliptin (SYR-472, Zafatek), Novel Once-Weekly Treatment for Type 2 Diabetes, Inhibits Dipeptidyl Peptidase-4 (DPP-4) via a Non-Covalent Mechanism 2016 ·PLoS ONE ·Charles E. Grimshaw, Andy Jennings, Ruhi Kamran, Hikaru Ueno, Nobuhiro Nishigaki, Takuo Kosaka, Akiyoshi Tani, Hiroki Sano, (unknown), (unknown), Lihong Shi, Koji Takeuchi	43
5	Design, synthesis and optimization of novel Alk5 (activin-like kinase 5) inhibitors 2016 ·Bioorganic & Medicinal Chemistry Letters ·Haixia Wang, J. David Lawson, (unknown), Ruhi Kamran, Mark S. Hixon, (unknown), Douglas R. Dougan, M. Sabat	10
6	A Fragment-Based Approach to IdentifyingS-Adenosyl-l-methionine -Competitive Inhibitors of CatecholO-Methyl Transferase (COMT). 2014 ·Journal of Medicinal Chemistry ·Marion Lanier, Géza Ambrus, Derek C. Cole, Richard Davenport, (unknown), Richard Fosbeary, Andy Jennings, (unknown), Yusuke Kamada, Ruhi Kamran, Shin-ichi Matsumoto, Atsushi Mizukami, (unknown), Kengo Okada, Kumar Singh Saikatendu, (unknown), Haihong Wu, Mark S. Hixon	10
7	Discovery of novel benzo[b][1,4]oxazin-3(4H)-ones as poly(ADP-ribose)polymerase inhibitors 2013 ·Bioorganic & Medicinal Chemistry Letters ·Anthony R. Gangloff, Jason W. Brown, Ron de Jong, Douglas R. Dougan, Charles E. Grimshaw, Mark S. Hixon, Andy Jennings, Ruhi Kamran, Andre A. Kiryanov, Shawn M. O’Connell, Ewan R. Taylor, (unknown)	28
8	Hexahydro-pyrrolo- and hexahydro-1H-pyrido[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase 2008 ·Bioorganic & Medicinal Chemistry Letters ·Frank Ruebsam, Zhongxiang Sun, Benjamin K. Ayida, Stephen E. Webber, Yuefen Zhou, Qiang Zhao, Charles R. Kissinger, Richard E. Showalter, Amit Shah, (unknown), Rupal Patel, Laurie A. LeBrun, Ruhi Kamran, Maria V. Sergeeva, Darian M. Bartkowski, Thomas G. Nolan, Daniel A. Norris, (unknown)	10
9	Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 5: Exploration of pyridazinones containing 6-amino-substituents 2008 ·Bioorganic & Medicinal Chemistry Letters ·Peter S. Dragovich, (unknown), David A. Ellis, Qing Han, Ruhi Kamran, Charles R. Kissinger, Laurie A. LeBrun, Lian‐Sheng Li, Douglas E. Murphy, (unknown), Rupal Patel, Frank Ruebsam, Maria V. Sergeeva, Amit Shah, Richard E. Showalter, Chinh Van Tran, (unknown), Stephen E. Webber, (unknown), Yuefen Zhou	20
10	Widespread occurrence of rhizomania-like disease of sugarbeet in Fars. 1996 ·Bīmārīhā-yi giyāhī (Online)/Bīmārīhā-yi giyāhī (Print) ·K. Izadpanah, (unknown), Ruhi Kamran, (unknown), (unknown), (unknown)	10
11	Isolation and identification of bean yellow mosaic and tobacco ringspot viruses from Gladiolus in Shiraz. 1981 ·Bīmārīhā-yi giyāhī (Online)/Bīmārīhā-yi giyāhī (Print) ·Ruhi Kamran, K. Izadpanah	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact